Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.410
0.00 (0.00%)
Apr 21, 2025, 4:00 PM EDT - Market closed
Xenetic Biosciences Market Cap
Xenetic Biosciences has a market cap or net worth of $3.93 million as of April 24, 2025. Its market cap has decreased by -44.61% in one year.
Market Cap
3.93M
Enterprise Value
-2.23M
1-Year Change
-44.61%
Ranking
Category
Stock Price
$2.41
Market Cap Chart
Since June 30, 2016, Xenetic Biosciences's market cap has decreased from $47.70M to $3.93M, a decrease of -91.76%. That is a compound annual growth rate of -24.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 3.70M | -40.32% |
| Dec 31, 2024 | 6.20M | 16.98% |
| Dec 29, 2023 | 5.30M | 23.26% |
| Dec 30, 2022 | 4.30M | -75.14% |
| Dec 31, 2021 | 17.30M | 35.16% |
| Dec 31, 2020 | 12.80M | 54.22% |
| Dec 31, 2019 | 8.30M | -46.10% |
| Dec 31, 2018 | 15.40M | -7.78% |
| Dec 29, 2017 | 16.70M | -53.09% |
| Dec 30, 2016 | 35.60M | -25.37% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.57B |
| UnitedHealth Group | 389.05B |
| Johnson & Johnson | 378.15B |
| AbbVie | 301.01B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 225.27B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |